AS PER THE ATTACHED FILE

Date: 05.11.2026 The General Manager Bombay Stock Exchange & Listing Corporate Relationship Department, 1st Floor, New Trading Ring, Rotunda Building PJ Tower, Dalal Street, Fort Mumbai-400001 Scrip code – 506935 ISIN- INE423K01015 Subject: Outcome of Board Meeting held on 05.11.2026, Thursday, started at 3:00 PM. And concluded at 3:30 PM. at the Registered Office of the company situated at A-7, Sector- 7, Noida- 201301 Dear Sir/Madam, This is to inform you that Board of Directors of the Company, Continental Chemicals Limited, in their board meeting held on Thursday, 05.11.2026 which started at 3:00 P.M. and concluded at 3:30 P.M. at the Registered Office of the company situated at A-7, Sector-7, Noida- 201301 considered and approved the following matters: A) The Board of Directors approved the Unaudited financial results and limited review report for the 02nd quarter ended on 30th September 2026. B) Pursuant to SEBI (LODR) Regulations, 2015, the Board took note on quarterly compliances done for the 02nd quarter ended on 30th September 2026. This is for your information and records Thanking you, Your Faithfully, For Continental Chemicals Limited Sakshi Dhawan Company Secretary (Membership No: ACS 33279) SSVS AND CO, 209, KRISHNA APRA PLAZA CHARTERED ACCOUNTANTS SECTOR -18, NOIDA LIMITED REVIEW REPORT THE BOARD OF DIRECTORS CONTINENTAL CHEMICALS LIMITED 1. We have reviewed the accompanying statement of unaudited standalone financial results of CONTINENTAL CHEMICALS LIMITED for the quarter and half year ended 30" September, 2026, being submitted by the company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. The preparation of the Statement in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 (Ind AS) “Interim Financial Reporting” prescribed under Section 133 of the Companies Act 2013 read with Rule 3 of Companies (Indian Accounting Standard) Rules 2015 read with SEBI Circular No. CIR/CFD/FAC/62/2016 dated July 05, 2016 is the responsibility of the company’s management and has been approved by the Board of Directors/ committee of Board of Directors. Our responsibility is to issue a report on these financial statements based on our review. 3. We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity” issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement of standalone unaudited financial results prepared in accordance with the recognition and measurement principal laid down in the applicable Indian accounting standards (“Ind AS") specified under section 133 of Companies Act 2013, read with relevant rules issued there under and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to be disclosed, or that it contains any material misstatement. For SSVS AND CO Chartered Accounta Firm Registration No: (Vipul Sharma) (Partner) M.No.74437 Place: Noida Date: 05° November ,2026 UDIN: 260144 454W BEAKCA22060 Tel, :91-120-2423316 E-mail ; info@continentalsoft.com Chemicals :nkc@continentalsoft.com Web - www.continentalchomicalsitd.c CIN :124123UP1984PLC0147 Regd. & Head Office : A-7, Sector-7, Noida-201301 (U.P.) India GST No. : Q9AAACC1412B27H CONTINENTAL CHEMICALS LIMITED Balance Sheet as at 20th September 2026 As at 30.09.2026 As at 31.03.2026 ASSETS Non-current assets (a) Property, Plant and Equipment 196.67 (6) Investment property 59.74 (c) Other non-current assets 32.75 Current assets (a) Financial Assets Trade receivables Cash and cash equivalents 2.26 Bank Balance other than Cash and cash equivalents 361.07 (6) Other current assets 65 (c) Income Tax Assets(Net) 10.28 (c) Deferred tax Asset (Net) EQUITY AND LIABILITIES Equity {@ ) Equity Share capital (6 ) Other Equity Liabilities Non-current liabilities (a) Financial Liabilities Borrowings (b ) Provisions Deferred Tax Liaility Current liabilities (a) Short Term Borrowing (b) Trade and other payable - Total outstanding dues of Micro and Small Enterprises - Total outstanding dues of creditors other than micro and small (c) Financial Liabilities Other financial liabilities (d) Other current liabilities Provisions Total Equity and Liabilities Continental[ YT 5. Chentirals Web : www.continentalchemicalsitd.com CIN :124123UP1984PLC014111 GST No. : O9AAACC1412B22H Regd. & Head Office : A-7, Sector-7, Noida-201301 (U.P.) India REGISTERED OFFICE: A-7, SECTOR-VII, NOIDA-201301, U P Tel : 91-120-2423316 Email: info@continentalscoofmt, nkc@icontinentalsoft.com web: www.continentalchemicalsltd.com UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND SIX MONTH ENDED 30TH SEPTEMBER, 2026 — Amouinn latkh except EPS l 2 3 4 5 6 | Sr. No. |Particu 3 Months | 3 Months 6 Months 6 Months “= Ended Ended Ended _| **** —_ feta 30.09.2026 | 30.09.2025 30.09 2025 | 30.09.2026 | 31.03.2026 ! Income from Operations (a) Revenue from Operations 6.57 5.98 5.74 11.79 12.31 25.52 (b) Other Income 41.74 34.96 36.93 69.91 78.67 142.28 Total Revenue from Operations 48.31 40.94 42.67 81.70 90.98] __167,80 2 =} Expenditere a) Cost of Material Consumed 0,00 | 0.00 0.00 0.00 0.00 0.00 b) Purchase of Stock-in-Trade 0.00 0.00 0.00 0.00 0.00 | 0.00 c) Change in inventories of Finished goods, Work-in-progress and stock-in-trade 0.00 0.00 0.00 0.00 0.00 0.00 jd) Employee Benefits Expense 13,99 14.59 [4.25 28.92 28.24 $4.16 e) Finance Cost 1.14 1,06 L.1S 2.14 2.29 | 4.22 f) Depreciation and amortisation expense 2.07 1.88 3.69 4.80 5.76 11,96 g) Other expenditure L 16.68 9.03 10.83 15.19 27.51 38.65 Total Expenses 33.88 26.56 29.92 $1.06 63.80 109.04 3 Profit before exceptional & tax (1-2) 14.43 | 14.38 12.75 30.64 27.18 r am 4 Exceptional Items | 0.00 ie! 0.00 0.00 0.00 7 0.00 5 Profit before tax (3-4) 14,43 14.38 12.75 30.64 27.18 I $8.76 6 Tax Expense Current Tax 1.83 2.08 14) 3.36 | 3.24 730 Income Tax for earlier year 0.00 0.00 0.00 0.00 0.00 0.00 a | Deffered tax 1.34 0.72 | (0.20) 130 114 0.25 Total tax expenses 3.17 | ao 1.21 4.66 | 4.38 7.55 7 Profit for the periad (5-6) 11.26 11.58 11.54 25.97 | 22.80 ij 51.21 8 Other comprehensive Income | | a) 1) Items that will not be be classified to profit or loss i (0.45) (0.25) (0.02) (0.18) stat (0.62) ii) IncomeTax relating to Items that will not be reclassified to profit or foss i 0.12 0.07 0.00 0.05 6.12 0.16 b) (i) Items that will be classified to profit or loss 0.00 0.00 0.00 0.00 0.00 0.00 (ii) Income tax relating to items that will be reclassified (o profit or loss t 0.00 0.00 0.00 0.00 | 0.00 0.00 Other comprehensive Income (0.33) (0.18) (0.02) (0.13) (0.35) (0.46) 9 Total Comprehensive income for the period ( 7+8) 11.59 11.76 11.56 26,10 23.15 51.67 10 = | Paid-up Eq Share capital (Face Value of Rs 10/-) 224.90 224.90) 224.90 224.90 | 224,90 224.90 it Other Equity l 329,83 12 |EPS (Im Rs.) (basic & diluted) |. Basic (Not annualized) a0 0.5| 051 11s Tol | 228 . Diluted (Not annualized) 0.50 051 0.51 1.15 | 1.01 | 2.28 SGREDERE Sana Notes The above financial result are reviewed by audit committee and thereby haye been taken on records by board of Director in their meeting held on 05-11-2026 2 _|Previous period [Showing first 8,000 characters — download PDF for full document]